학술논문
Randomized phase 2 trial of Intravenous Gamma Globulin (IVIG) for the treatment of acute vaso-occlusive crisis in patients with sickle cell disease: Lessons learned from the midpoint analysis
Document Type
Article
Author
Source
In Complementary Therapies in Medicine August 2020 52
Subject
Language
ISSN
0965-2299